Clinical trials
Phase 3 Generalized Anxiety Disorder trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2004 | 4 |
| 2005 | 2 |
| 2006 | 8 |
| 2007 | 2 |
| 2008 | 9 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
| Terminated | 6 |
| Recruiting | 5 |
| Active, not recruiting | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 6 |
| AstraZeneca | 5 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 4 |
| Cephalon | 3 |
| Forest Laboratories | 3 |
| Takeda | 3 |
| Definium Therapeutics US, Inc. | 2 |
| Jazz Pharmaceuticals | 2 |
| University of California, Los Angeles | 2 |
| Ann & Robert H Lurie Children's Hospital of Chicago | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Generalized Anxiety Disorder | 44 |
| Anxiety Disorders | 22 |
| Phobia, Social | 4 |
| Anxiety, Separation | 3 |
| Mood Disorders | 3 |
| Attention Deficit Disorder with Hyperactivity | 1 |
| Bipolar Disorder | 1 |
| Major Depressive Disorder | 1 |
| Obsessive-Compulsive Disorder | 1 |
| Phobic Disorders | 1 |
Trials
Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.